§ 13F · FUND PROFILE
NEA Management Company, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 26Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$192M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | ACLX | Arcellx, Inc. | 3.05M | $350M | 19.9% | ±0% |
| 2 | CELC | Celcuity Inc. | 2.29M | $261M | 14.8% | −35% |
| 3 | SGP | Spyglass Pharma, Inc. | 7.39M | $192M | 10.9% | NEW |
| 4 | TRVI | Trevi Therapeutics, Inc. | 13.22M | $158M | 9.0% | ±0% |
| 5 | SVRA | Savara, Inc. | 24.47M | $134M | 7.6% | ±0% |
| 6 | GLUE | Monte Rosa Therapeutics, Inc. | 7.69M | $127M | 7.2% | ±0% |
| 7 | MBX | MBX Biosciences, Inc. | 3.61M | $108M | 6.1% | ±0% |
| 8 | ZBIO | Zenas BioPharma, Inc. | 4.02M | $79M | 4.5% | +14% |
| 9 | COUR | Coursera, Inc. | 12.87M | $75M | 4.3% | ±0% |
| 10 | AUPH | Aurinia Pharmaceuticals, Inc. | 3.97M | $59M | 3.3% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE NEA SIGNAL
AC read
NEA Management Company, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed